Aragon, Rex B.
HRN: 21-27-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFUROXIME 750MG (VIAL)
05/06/2022
05/12/2022
IVT
1.5g Then 750mg
Q8hrs
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes